Incidence of chemotherapy‐related cardiac dysfunction in cancer patients
Key Points:
- Examines the prevalence and risk factors of cardiac dysfunction in cancer patients undergoing chemotherapy.
- Discusses mechanisms of cardiotoxicity, including effects on myocardial function and vascular health.
- Highlights strategies for early detection, prevention, and management to improve patient outcomes.
Description
“Incidence of Chemotherapy-Related Cardiac Dysfunction in Cancer Patients” explores the cardiovascular risks associated with cancer treatments. It provides insights into the incidence, mechanisms, and prevention of chemotherapy-induced cardiac dysfunction, helping clinicians balance oncologic efficacy with cardiotoxicity management.
Be the first to review “Incidence of chemotherapy‐related cardiac dysfunction in cancer patients”
Reviews
There are no reviews yet.